MRNA

Moderna
D

MRNA

39.110
USD
3.22
(8.97%)
Market Open
Volume
504,765
EPS
-9
Div Yield
-
P/E
-7
Market Cap
15,084,858,191
OverviewSignalsIdeasNews
Signals
Related Instruments
    ABBV
    ABBV
    -2.480
    (-1.44%)
    169.920 USD
    AZN
    AZN
    0.110
    (0.16%)
    68.030 USD
    BMY
    BMY
    -0.430
    (-0.75%)
    56.620 USD
    BNTX
    BNTX
    -3.060
    (-2.61%)
    114.280 USD
    GSK
    GSK
    -0.160
    (-0.47%)
    33.620 USD
    JNJ
    JNJ
    -4.765
    (-3.22%)
    143.450 USD
    MRK
    MRK
    -0.480
    (-0.50%)
    95.710 USD
    N
    NVAX
    0.09000
    (1.02%)
    8.91000 USD
    PFE
    PFE
    -0.276
    (-1.04%)
    26.355 USD
    REGN
    REGN
    5.49
    (0.80%)
    692.81 USD
    More
News

Title: Moderna

Sector: Healthcare
Industry: Biotechnology
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.